Pfizer Inc. | Large-cap | Healthcare
$24.19
-0.21%
| Pfizer Stock Comparison:
Pfizer vs Eli Lilly andPfizer vs Johnson & JohnsonPfizer vs Merck & CoPfizer vs AmgenPfizer vs Gilead SciencesPfizer vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 63.6B
Gross Profit 45.8B 71.94%
Operating Income 14.9B 23.48%
Net Income 8.1B 12.67%
EPS (Diluted) $1.41

Balance Sheet Metrics

Total Assets 213.4B
Total Liabilities 124.9B
Shareholders Equity 88.5B
Debt to Equity 1.41

Cash Flow Metrics

Operating Cash Flow 8.5B
Free Cash Flow 9.8B

Revenue & Profitability Trend

Pfizer Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 63.6B 58.5B 100.3B 81.3B 41.7B
Cost of Goods Sold 17.9B 25.0B 34.3B 30.8B 8.5B
Gross Profit 45.8B 33.5B 66.0B 50.5B 33.2B
Operating Expenses 25.6B 25.4B 25.1B 23.1B 21.0B
Operating Income 14.9B 3.4B 37.3B 23.7B 8.8B
Pre-tax Income 8.0B 1.1B 34.7B 24.3B 7.0B
Income Tax -28.0M -1.1B 3.3B 1.9B 370.0M
Net Income 8.1B 2.2B 31.4B 22.0B 9.2B
EPS (Diluted) $1.41 $0.37 $5.47 $3.85 $1.71

Income Statement Trend

Pfizer Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 50.4B 43.3B 51.3B 59.7B 35.1B
Non-Current Assets 163.0B 183.2B 145.9B 121.8B 119.2B
Total Assets 213.4B 226.5B 197.2B 181.5B 154.2B
Liabilities
Current Liabilities 43.0B 47.8B 42.1B 42.7B 25.9B
Non-Current Liabilities 81.9B 89.4B 59.2B 61.3B 64.8B
Total Liabilities 124.9B 137.2B 101.3B 104.0B 90.8B
Equity
Total Shareholders Equity 88.5B 89.3B 95.9B 77.5B 63.5B

Balance Sheet Composition

Pfizer Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 8.1B 2.2B 31.4B 22.5B 7.0B
Operating Cash Flow 8.5B -907.0M 27.5B 32.6B 8.5B
Investing Activities
Capital Expenditures -2.9B -3.9B -3.2B -2.7B -2.2B
Investing Cash Flow 2.7B -32.3B -19.7B -22.5B -4.2B
Financing Activities
Dividends Paid -9.5B -9.2B -9.0B -8.7B -8.4B
Financing Cash Flow -31.0B 26.1B -18.9B -9.9B -48.0B
Free Cash Flow 9.8B 4.8B 26.0B 29.9B 12.2B

Cash Flow Trend

Pfizer Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 17.41
Forward P/E 8.20
Price to Book 1.51
Price to Sales 2.19
PEG Ratio 8.20

Profitability Ratios

Profit Margin 12.62%
Operating Margin 35.17%
Return on Equity 8.62%
Return on Assets 4.79%

Financial Health

Current Ratio 1.26
Debt to Equity 68.84
Beta 0.49

Per Share Data

EPS (TTM) $1.38
Book Value per Share $15.89
Revenue per Share $11.02

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
pfe 136.6B 17.41 1.51 8.62% 12.62% 68.84
Eli Lilly and 691.8B 62.76 46.33 77.28% 22.67% 243.61
Johnson & Johnson 364.1B 16.83 4.66 29.45% 24.42% 66.90
Merck & Co 198.5B 11.49 4.12 39.29% 27.27% 71.99
Amgen 146.5B 24.84 23.60 105.67% 17.39% 924.46
Gilead Sciences 132.1B 22.31 6.90 32.65% 20.76% 130.79

Financial data is updated regularly. All figures are in the company's reporting currency.